Cargando…
SOM0226, a repositioned compound for the treatment of TTR amyloidosis
Autores principales: | Reig, Núria, Ventura, Salvador, Salvadó, Maria, Gámez, Josep, Insa, Raúl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642128/ http://dx.doi.org/10.1186/1750-1172-10-S1-P9 |
Ejemplares similares
-
Non-invasive risk stratification of patients with TTR amyloidosis
por: Scherer, Katrin A, et al.
Publicado: (2013) -
Treatment of transthyretin (TTR) amyloid cardiomyopathy with an antisense oligonucleotide inhibitor of TTR synthesis
por: Benson, Merrill D, et al.
Publicado: (2015) -
MALDI spectrometry for salivary samples analysis : a new tool for TTR amyloidosis diagnosis
por: Seguier, Julie, et al.
Publicado: (2015) -
Identification of a new variant of TTR involved in familial amyloid cardiomyopathy (FAC) in Brazil: from the patient to the protein
por: Ferreira, Priscila, et al.
Publicado: (2015) -
The phenotypical expression of an European inherited TTR amyloidosis in Brazil
por: Cruz, Márcia Waddington, et al.
Publicado: (2015)